Champions Oncology (CSBR) Total Non-Current Liabilities (2016 - 2025)
Historic Total Non-Current Liabilities for Champions Oncology (CSBR) over the last 15 years, with Q4 2025 value amounting to $25.9 million.
- Champions Oncology's Total Non-Current Liabilities rose 680.83% to $25.9 million in Q4 2025 from the same period last year, while for Oct 2025 it was $25.9 million, marking a year-over-year increase of 680.83%. This contributed to the annual value of $28.5 million for FY2025, which is 308.68% up from last year.
- According to the latest figures from Q4 2025, Champions Oncology's Total Non-Current Liabilities is $25.9 million, which was up 680.83% from $26.9 million recorded in Q3 2025.
- Champions Oncology's Total Non-Current Liabilities' 5-year high stood at $29.1 million during Q2 2023, with a 5-year trough of $17.0 million in Q1 2021.
- For the 5-year period, Champions Oncology's Total Non-Current Liabilities averaged around $25.2 million, with its median value being $25.9 million (2022).
- In the last 5 years, Champions Oncology's Total Non-Current Liabilities surged by 4465.82% in 2021 and then tumbled by 1258.79% in 2024.
- Champions Oncology's Total Non-Current Liabilities (Quarter) stood at $21.0 million in 2021, then rose by 26.57% to $26.6 million in 2022, then grew by 4.35% to $27.7 million in 2023, then decreased by 12.59% to $24.2 million in 2024, then increased by 6.81% to $25.9 million in 2025.
- Its Total Non-Current Liabilities stands at $25.9 million for Q4 2025, versus $26.9 million for Q3 2025 and $28.5 million for Q2 2025.